BCYC FY 2018 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+246.4% YoY

Gross Profit

-$14M-190.9% margin

Operating Income

-$22M-304.7% margin

Net Income

-$22M-306.1% margin

EPS (Diluted)

$-1.64

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$27M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$82M

Total Liabilities

$151M

Stockholders' Equity

-$70M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$2M	+246.4%
Gross Profit	-$14M	-$10M	-38.9%
Operating Income	-$22M	-$16M	-34.1%
Net Income	-$22M	-$16M	-34.4%